Jennifer Grunfeld

Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression

Ewa Wajs, Leah Aluisio, Richard Holder et al. · The Journal of Clinical Psychiatry · 2020 · 285 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study

Mark E. Schmidt, Michael R. Liebowitz, Murray B. Stein et al. · Neuropsychopharmacology · 2020 · 101 citations · Full text

Medicine, Pharmacology, Psychiatry +16

Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

Paul Glue, Colleen Loo, Johnson Fam et al. · Nature Medicine · 2024 · 55 citations · Full text

Medicine, Pharmacology, Psychiatry +15

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial

Stephen Macfarlane, Timo Grimmer, Ken Teo et al. · The Journal of Prevention of Alzheimer s Disease · 2025 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Understanding Treatment Preferences of Australian Patients Living with Treatment-Resistant Depression

Simon Fifer, Andrea Puig, Vanessa Sequeira et al. · Patient Preference and Adherence · 2021 · 13 citations · Full text

Nursing, Psychiatry, Behavioral Health +16